Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.98M Sell
16,509
-152
-0.9% -$52K 0.1% 200
2026
Q1
$5.86M Sell
16,661
-128
-0.8% -$45.6K 0.2% 98
2025
Q4
$3.76M Sell
16,789
-6,407
-28% -$2.03M 0.09% 221
2025
Q3
$6.55M Sell
23,196
-807
-3% -$234K 0.13% 165
2025
Q2
$6.7M Buy
24,003
+12,447
+108% +$3.53M 0.14% 152
2025
Q1
$3.6M Sell
11,556
-4,695
-29% -$1.39M 0.11% 186
2024
Q4
$4.24M Buy
16,251
+477
+3% +$142K 0.17% 127
2024
Q3
$5.08M Buy
15,774
+1,461
+10% +$478K 0.21% 109
2024
Q2
$4.47M Buy
14,313
+4,697
+49% +$1.38M 0.21% 102
2024
Q1
$2.73M Buy
9,616
+188
+2% +$55K 0.14% 160
2023
Q4
$2.72M Buy
9,428
+6,643
+239% +$1.81M 0.16% 144
2023
Q3
$748K Buy
2,785
+292
+12% +$72.9K 0.06% 306
2023
Q2
$554K Sell
2,493
-898
-26% -$208K 0.04% 399
2023
Q1
$820K Buy
3,391
+19
+0.6% +$4.66K 0.06% 328
2022
Q4
$886K Sell
3,372
-176
-5% -$47.2K 0.07% 296
2022
Q3
$800K Buy
3,548
+387
+12% +$93.8K 0.07% 295
2022
Q2
$769K Sell
3,161
-491
-13% -$120K 0.06% 312
2022
Q1
$883K Sell
3,652
-98
-3% -$22.5K 0.06% 304
2021
Q4
$844K Sell
3,750
-197
-5% -$41.6K 0.05% 333
2021
Q3
$839K Buy
3,947
+178
+5% +$41K 0.06% 189
2021
Q2
$919K Buy
3,769
+245
+7% +$60.3K 0.07% 285
2021
Q1
$877K Sell
3,524
-379
-10% -$90.4K 0.08% 262
2020
Q4
$897K Sell
3,903
-6,254
-62% -$1.44M 0.09% 240
2020
Q3
$2.58M Buy
+10,157
New +$2.52M 0.2% 117
2020
Q1
Sell
-5,289
Closed -$1.27M 116
2019
Q4
$1.27M Buy
+5,289
New +$1.17M 0.16% 156

Other funds holding AMGN

J.W. Cole Advisors's AMGN Position: Q2 2026 in Review

J.W. Cole Advisors reduced its Amgen (AMGN) stake by 0.91% in Q2 2026, selling an estimated $52K and leaving 16,509 shares worth $5.98M. The position accounts for 0.1% of the portfolio, ranked #200.

J.W. Cole Advisors first reported a position in AMGN in Q4 2019 and has held it in 25 quarters since. The position peaked at $6.7M in Q2 2025. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • J.W. Cole Advisors held 16,509 shares of Amgen worth $5.98M as of Q2 2026.
  • J.W. Cole Advisors sold 152 Amgen shares in Q2 2026, an estimated $52K.
  • Amgen made up 0.1% of J.W. Cole Advisors's portfolio in Q2 2026, its #200 holding.
  • J.W. Cole Advisors first reported a position in Amgen in Q4 2019 and has held it in 25 quarters since.
  • J.W. Cole Advisors's Amgen position peaked at $6.7M in Q2 2025.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.